Israel-based Teva pharmaceuticals received U.S. approval to market a generic version of the anti-depressant Prozac. Teva shares rose more than 1 percent on the Tel Aviv Stock Exchange following the company’s announcement.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
